Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Jaime Sanz, Pau Montesinos, David Martinez, Ignacio Lorenzo, Javier Palau, Luis Larrea, Dolores Planelles, Guillermo Martin, Isidro Jarque, Javier De La Rubia, Federico Moscardo, Jesus Martinez, Miguel Angel Sanz, Guillermo F Sanz, MD, PhD

Blood (2010) 116 (21): 1339.

https://doi.org/10.1182/blood.V116.21.1339.1339

Published: 2010

Journal Articles

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Myeloid Leukemia (AML)

Jai me Sanz, MD, Silvana Saavedra, MD, Pau Montesinos, MD, Ignacio Lorenzo, MD-PhD, Javier Palau, MDPhD, Luis Larrea, MD-PhD, Dolores Planelles, MD, Guillermo Martín, MD-PhD, Leonor Senent, MD, Isidro Jarque, MD-PhD, Javier de la Rubia, Federico Moscardo, MD, Jesus Martinez, MD-PhD, Shirley Weiss, Miguel A. Sanz, MD, PhD, Guillermo Sanz, MD, PhD

Blood (2008) 112 (11): 4401.

https://doi.org/10.1182/blood.V112.11.4401.4401

Published: 2008

Journal Articles

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (ALL).

Jaime Sanz, MD, Ignacio Lorenzo, MD-PHD, Pau Montesinos, MD, Leonor Senent, MD, Luis Larrea, MD-PHD, Dolores Planelles, MD, Guillermo Martin, MD-PHD, Jose Cervera, MD, Isidro Jarque, MD, Javier de la Rubia, MD, Guillermo Orti, MD, Miguel Scaff, MD, Mari Liz Paciello, MD, Federico Moscardo, MD, Monica Romero, MD, Luis Benlloch Biologist, Miguel A. Sanz, MD-PHD, Guillermo Sanz, MD-PHD

Blood (2007) 110 (11): 2024.

https://doi.org/10.1182/blood.V110.11.2024.2024

Published: 2007

Journal Articles

Long-Term Outcome and Prognostic Factors after Single-Unit Umbilical Cord-Blood Transplantation (UCBT) for Adults with Hematologic Malignancies.

Guillermo Sanz, MD, Susana Cantero, MD, Luis Larrea, MD, Dolores Planelles, PhD, Ignacio Lorenzo, MD, Barbara Banlloch, PhD, Luis Banlloch, PhD, Leonor Senent, MD, Pau Montesinos, MD, Jose Cervera, MD, Carmen Jimenez, MD, Guillermo Martin, MD, Jesus Martinez, MD, Isidro Jarque, MD, Javier De la Rubia, MD, Miguel A. Sanz, MD

Blood (2006) 108 (11): 3129.

https://doi.org/10.1182/blood.V108.11.3129.3129

Published: 2006

Journal Articles

Prophylaxis of Cytomegalovirus (CMV) Infection and Disease after Unrelated-Donor Umbilical Cord-Blood Transplantation (UCBT) with Intravenous Ganciclovir or Oral Valganciclovir.

Guillermo Sanz, MD, PhD, Susana Cantero, MD, Ignacio Lorenzo, MD, PhD, Barbara Benlloch, PhD, Luis Benlloch, PhD, Maria Narvaez, MD, Dolores Planelles, PhD, Luis Larrea, MD, PhD, Isidro Jarque, MD, Phd, Carmen Jimenez, MD, Maria L. Marty, MD, Miguel Gobernado, MD, Miguel A. Sanz, MD, PhD

Blood (2005) 106 (11): 5460.

https://doi.org/10.1182/blood.V106.11.5460.5460

Published: 2005

Journal Articles

Outcome and Prognostic Factors after Unrelated Donor Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies Transplanted in Early Disease Stages.

Guillermo Sanz, MD, PhD, Ignacio Lorenzo, MD, PhD, Federico Moscardo, MD, Dolores Planelles, PhD, Luis Larrea, MD, PhD, Leonor Senent, MD, Luis Benlloch, PhD, Jaime Sanz, MD, Pau Montesinos, MD, Noemi Puig, MD, Carmen Jimenez, MD, Jesus Martinez, MD, Guillermo Martin, MD, PhD, Isidro Jarque, MD, PhD, Javier de la Rubia, MD, PhD, Maria A. Soler, MD, Maria L. Marty, MD, Miguel A. Sanz, MD, PhD

Blood (2004) 104 (11): 2149.

https://doi.org/10.1182/blood.V104.11.2149.2149

Published: 2004

Journal Articles

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies

Blood (2001) 98 (8): 2332–2338.

https://doi.org/10.1182/blood.V98.8.2332

Published: 2001

NARROW

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Myeloid Leukemia (AML)

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (ALL).

Long-Term Outcome and Prognostic Factors after Single-Unit Umbilical Cord-Blood Transplantation (UCBT) for Adults with Hematologic Malignancies.

Prophylaxis of Cytomegalovirus (CMV) Infection and Disease after Unrelated-Donor Umbilical Cord-Blood Transplantation (UCBT) with Intravenous Ganciclovir or Oral Valganciclovir.

Outcome and Prognostic Factors after Unrelated Donor Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies Transplanted in Early Disease Stages.

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

CD34+ Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Myeloid Leukemia (AML)

Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (ALL).

Long-Term Outcome and Prognostic Factors after Single-Unit Umbilical Cord-Blood Transplantation (UCBT) for Adults with Hematologic Malignancies.

Prophylaxis of Cytomegalovirus (CMV) Infection and Disease after Unrelated-Donor Umbilical Cord-Blood Transplantation (UCBT) with Intravenous Ganciclovir or Oral Valganciclovir.

Outcome and Prognostic Factors after Unrelated Donor Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies Transplanted in Early Disease Stages.

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only